Clinical trial
Fetched
Post
clinicaltrials.gov
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
(2024).
DINO RCT - Treating Anxiety in Children With Autism.
ClinicalTrials.gov.
Hugo W. Moser Research Institute at Kennedy Krieger, Inc..
- Publication date
-
2 Jan 2024
- Identifier
-
NCT06066983
- Authors
-
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Source
- ClinicalTrials.gov
- Reference type
- clinical_trial
- Publisher
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Metadata source
- clinicaltrials.gov
Abstract
Anxiety is prevalent in young children, under 7 years of age, with autism. Yet, few studies have examined anxiety interventions for this age range, and only one anxiety treatment study has included young children with cognitive and language delays. Anxiety treatment models utilizing cognitive-behavioral therapy (CBT), adapted for children with autism, are empirically supported in school-age autistic children. Further, preliminary evidence suggests CBT approaches may reduce intolerance of uncertainty (IU), a mechanistic construct that may contribute to the maintenance of anxiety in autistic children. This study seeks to address the existing gap in anxiety treatment by examining the feasibility and preliminary efficacy of a novel, telehealth CBT intervention, DINO Strategies for Anxiety and intolerance of Uncertainty Reduction (DINOSAUR), which targets both anxiety and IU in young autistic children.